(Q44141083)

English

Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design

scientific article published on 16 September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design (English)

1 reference

Europe PubMed Central

30 November 2017

1 reference

based on heuristic

inferred from title

vaccine engineering

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

Joseph G Joyce

1

1 reference

Europe PubMed Central

30 November 2017

William M Hurni

2

1 reference

Europe PubMed Central

30 November 2017

Michael J Bogusky

3

1 reference

Europe PubMed Central

30 November 2017

Victor M Garsky

4

1 reference

Europe PubMed Central

30 November 2017

Xiaoping Liang

5

1 reference

Europe PubMed Central

30 November 2017

Michael P Citron

6

1 reference

Europe PubMed Central

30 November 2017

Renee C Danzeisen

7

1 reference

Europe PubMed Central

30 November 2017

Michael D Miller

8

1 reference

Europe PubMed Central

30 November 2017

John W Shiver

9

1 reference

Europe PubMed Central

30 November 2017

Paul M Keller

10

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

16 September 2002

1 reference

Europe PubMed Central

30 November 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

30 November 2017

277

1 reference

Europe PubMed Central

30 November 2017

48

1 reference

Europe PubMed Central

30 November 2017

45811-45820

1 reference

Europe PubMed Central

30 November 2017

Maturation of HIV envelope glycoprotein precursors by cellular endoproteases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

HIV entry and its inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

HIV-1 entry inhibitors in the side pocket

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Neutralization of HIV-1 by antibody

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Interactions between HIV-1 gp41 core and detergents and their implications for membrane fusion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Membrane-induced conformational change during the activation of HIV-1 gp41.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Atomic structure of a thermostable subdomain of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

HIV-1 gp41 tertiary structure studied by EPR spectroscopy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Protein design of an HIV-1 entry inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Effect of mobile phase on the oligomerization state of alpha-helical coiled-coil peptides during high-performance size-exclusion chromatography

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Trimerization specificity in HIV-1 gp41: analysis with a GCN4 leucine zipper model

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Predicting coiled coils by use of pairwise residue correlations

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

N- and C-domains of HIV-1 gp41: mutation, structure and functions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Genetic evidence that interhelical packing interactions in the gp41 core are critical for transition of the human immunodeficiency virus type 1 envelope glycoprotein to the fusion-active state

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Use of a conformationally restricted secondary structural element to display peptide libraries: a two-stranded alpha-helical coiled-coil stabilized by lactam bridges

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

A simplified method for determination of peptide-protein molar ratios using amino acid analysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Circular dichroism of biological membranes. I. Mitochondria and red blood cell ghosts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M205862200

21 January 2018

Identifiers

10.1074/JBC.M205862200

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44141083&oldid=2107052629"